Use of short-acting insulin aspart in managing older people with diabetes

Clinical Interventions in Aging

Volumn 4, Issue 1, 2009, Pages 187-190

  Marouf, Eltayeb ^a   Sinclair, Alan J ^a  

^a UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

Author keywords

Diabetes; Hypoglycemia; Insulin aspart; Older people

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN GLULISINE; ORAL ANTIDIABETIC AGENT;

AGE DISTRIBUTION; AGED; AGING; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC DIET; DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; ELDERLY CARE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MEAL; METABOLIC REGULATION; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET DISEASE; PATIENT SATISFACTION; PHARMACODYNAMICS; REVIEW; RISK REDUCTION; SIDE EFFECT; WEIGHT GAIN;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE;

EID: 66249138458     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Sinclair AJ, Croxson SCM. Diabetes mellitus. In: Tallis RC, Fillit HM, editors. Brocklehurst's textbook of geriatric medicine and gerontology, 6th ed. London: Churchill Livingstone; 2003. p. 1193-1218.
2. Spence JC. Some observations on sugar tolerance with special reference to variations found at different ages.QJ Med. 1921;14:314-326.
3. Davidson MB. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism. 1979;28(6):688-705.
4. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetolgia. 2006;49:1171-1721.
5. Hendra TJ, Sinclair AJ. Improving the care of elderly diabetic patients: the final report of the St Vincent Joint Task Force for diabetes. Age Ageing. 1997;26:3-6.
6. Sinclair AJ, Turnbull CJ, Croxson SCM. Document of care for older people with diabetes. Postgrad Med J. 1996;72:334-338.
7. Sinclair AJ, Turnbull CJ, Croxson SCM. Document of diabetes care for residential and nursing homes. Postgrad Med J. 1997;73:611-612.
8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
9. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103-117.
10. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
11. European Diabetes Working Party For Older People 2000-2003. Clinical Guidelines for Type 2 Diabetes Mellitus. Available from: www.eugms.org.
12. Simpson KL, Spencer CM. Insulin aspart. Drugs. 1999;57:759-765.
13. Lindholm A, Jacobsen LV. Clinical pharmacokinetics and pharmacodynamics of insulin aspart. Clin Pharmacokinet. 2001;40:641-659.
14. Hirsch IB, Insulin analogues. New Engl J Med. 2005;352:174-183.
15. Mudaliar S, Lindberg FA, Joyce M, et al. Insulin aspart (B28 Asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care. 1999;22:1501-1506.
16. Øterberg O, Erichsen L, Ingwersen SH, Plum A, Poulsen HE, Vicini P. Pharmacokinetic and pharmacodynamic properties of insulin aspart and human insulin. J Pharmacokinet Pharmacodyn. 2003;30:221-235.
17. Home PD, Lindholm A, Riis A. Insulin aspart vs human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus: a randomized controlled trial. Diabet Med. 2000;17:762-770.
18. Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care. 2000;23(5):583-588.
19. Gough SCL, Tibaldi J. Biphasic insulin aspart in type 2 diabetes mellitus: an evidence-based medicine review. Clin Drug Invest. 2007;27(5):299-324.
20. Chlup R, Zapletalova J, Seckar P, et al. Benefi ts of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus. Diabetes Technol Ther. 2007; 9(3):223-231.
21. Dailey G, Moses R, Rosenstock J, et al. Insulin glulisine provides improved glycemic control in patients with type 2 diabetes. Diabetes Care. 2004, 27:2363-2368.
22. Meneilly GS. A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes. Diabetes Obes Metab. 2007;9(5):754-755.
23. Warren ML, Conway MJ, Klaff LJ, Rosenstock J, Allen E. Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients. Diabetes Res Clin Pract. 2004;66(1):23-29.
24. Jang HC, Lee SR, Vaz JA. Biphasic insulin aspart 30 in the treatment of eldserly patients with type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMix study. Diabetes Obes Metab. 2009; 11(1):20-26.
25. Miyashita Y, Nishimura R, Nemoto M, Matsudaira T, et al. Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure. Cardiovasc Diabetol. 2008;7:16 doi:1186/ 1475-2840-7-16.